Exact Mass: 545.0811

Exact Mass Matches: 545.0811

Found 24 metabolites which its exact mass value is equals to given mass value 545.0811, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

dTDP-beta-L-4-epi-vancosamine

dTDP-L-epivancosamine; dTDP-beta-L-4-epi-vancosamine; dTDP-3-amino-2,3,6-trideoxy-3-methyl-beta-L-arabino-hexopyranose

C17H29N3O13P2 (545.1176)


   

dTDP-beta-L-vancosamine

dTDP-beta-L-vancosamine

C17H29N3O13P2 (545.1176)


   

5-(3-(4-(2-Chlorophenyl)-9-methyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepin-2-yl)-2-propynyl)phenanthridin-6(5H)-one

5-{3-[7-(2-chlorophenyl)-13-methyl-3-thia-1,8,11,12-tetraazatricyclo[8.3.0.0^{2,6}]trideca-2(6),4,7,10,12-pentaen-4-yl]prop-2-yn-1-yl}-5,6-dihydrophenanthridin-6-one

C31H20ClN5OS (545.1077)


   
   
   
   

N-[2-[(2-bromo-4,6-dinitrophenyl)azo]-5-[(2-cyanoethyl)allylamino]-4-methoxyphenyl]acetamide

N-[2-[(2-bromo-4,6-dinitrophenyl)azo]-5-[(2-cyanoethyl)allylamino]-4-methoxyphenyl]acetamide

C21H20BrN7O6 (545.0658)


   

CP-945598 HCl

Otenabant hydrochloride

C25H26Cl3N7O (545.1264)


C78272 - Agent Affecting Nervous System > C29728 - Anorexiant

   

Ziprasidone Impurity E

Ziprasidone Impurity E

C28H24ClN5OS2 (545.1111)


   

(2R)-2-[bis[3,5-bis(trifluoromethyl)phenyl]methyl]pyrrolidine,hydrochloride

(2R)-2-[bis[3,5-bis(trifluoromethyl)phenyl]methyl]pyrrolidine,hydrochloride

C21H16ClF12N (545.078)


   

(S)-2-{Bis[3,5-bis(trifluoromethyl)phenyl]methyl}pyrrolidine hydrochloride

(S)-2-{Bis[3,5-bis(trifluoromethyl)phenyl]methyl}pyrrolidine hydrochloride

C21H16ClF12N (545.078)


   

5-Chloro-N,N-bis[2-(ethoxy carbonyloxy) ethyl]-2-methoxy-4-(5-nitro-1,3-thiazol-2-ylazo) aniline

5-Chloro-N,N-bis[2-(ethoxy carbonyloxy) ethyl]-2-methoxy-4-(5-nitro-1,3-thiazol-2-ylazo) aniline

C20H24ClN5O9S (545.0983)


   

2-DEOXY-2-(4 5-DICHLOROPHTHALIMIDO)D-GL&

2-DEOXY-2-(4 5-DICHLOROPHTHALIMIDO)D-GL&

C22H21Cl2NO11 (545.0492)


   

5-(3-(4-(2-Chlorophenyl)-9-methyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepin-2-yl)-2-propynyl)phenanthridin-6(5H)-one

5-(3-(4-(2-Chlorophenyl)-9-methyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepin-2-yl)-2-propynyl)phenanthridin-6(5H)-one

C31H20ClN5OS (545.1077)


   

CDP-4-dehydro-6-deoxy-alpha-D-glucose

CDP-4-dehydro-6-deoxy-alpha-D-glucose

C15H21N3O15P2-2 (545.0448)


   

afrormosin-7-O-glucoside-6-O-malonate

afrormosin-7-O-glucoside-6-O-malonate

C26H25O13- (545.1295)


   

CDP-4-dehydro-6-deoxy-alpha-D-gulose

CDP-4-dehydro-6-deoxy-alpha-D-gulose

C15H21N3O15P2-2 (545.0448)


   

CDP-4-dehydro-6-deoxy-D-glucose(2-)

CDP-4-dehydro-6-deoxy-D-glucose(2-)

C15H21N3O15P2-2 (545.0448)


   

(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxylatopropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxylatopropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

C22H21N6O7S2- (545.0913)


   

ceftazidime(1-)

ceftazidime(1-)

C22H21N6O7S2 (545.0913)


A cephalosporin carboxylic acid anion formed by proton loss from the carboxy group of ceftazidime, a cephalosporin having 7beta-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino and 3-pyridinium-1-ylmethyl side-groups.

   

8-{7-amino-6,10-dihydroxy-3-methyl-1,9-dioxo-3h,4h-naphtho[2,3-c]pyran-8-ylidene}-10-hydroxy-3-methyl-3h,4h-naphtho[2,3-c]pyran-1,6,7,9-tetrone

8-{7-amino-6,10-dihydroxy-3-methyl-1,9-dioxo-3h,4h-naphtho[2,3-c]pyran-8-ylidene}-10-hydroxy-3-methyl-3h,4h-naphtho[2,3-c]pyran-1,6,7,9-tetrone

C28H19NO11 (545.0958)


   

(3r)-8-[(3r)-7-amino-6,10-dihydroxy-3-methyl-1,9-dioxo-3h,4h-naphtho[2,3-c]pyran-8-ylidene]-10-hydroxy-3-methyl-3h,4h-naphtho[2,3-c]pyran-1,6,7,9-tetrone

(3r)-8-[(3r)-7-amino-6,10-dihydroxy-3-methyl-1,9-dioxo-3h,4h-naphtho[2,3-c]pyran-8-ylidene]-10-hydroxy-3-methyl-3h,4h-naphtho[2,3-c]pyran-1,6,7,9-tetrone

C28H19NO11 (545.0958)


   

10-[5-(6-bromo-1h-indol-3-yl)-6-oxo-1h-pyrazin-2-yl]-1-hydroxy-4-imino-7-methyl-3,5,12-triazatetracyclo[6.6.1.0²,⁶.0⁹,¹³]pentadeca-2(6),9(13),10-trien-14-one

10-[5-(6-bromo-1h-indol-3-yl)-6-oxo-1h-pyrazin-2-yl]-1-hydroxy-4-imino-7-methyl-3,5,12-triazatetracyclo[6.6.1.0²,⁶.0⁹,¹³]pentadeca-2(6),9(13),10-trien-14-one

C25H20BrN7O3 (545.0811)


   

(3r)-7-amino-8-[(3r)-7,10-dihydroxy-3-methyl-1,6,9-trioxo-3h,4h-naphtho[2,3-c]pyran-8-yl]-10-hydroxy-3-methyl-3h,4h-naphtho[2,3-c]pyran-1,6,9-trione

(3r)-7-amino-8-[(3r)-7,10-dihydroxy-3-methyl-1,6,9-trioxo-3h,4h-naphtho[2,3-c]pyran-8-yl]-10-hydroxy-3-methyl-3h,4h-naphtho[2,3-c]pyran-1,6,9-trione

C28H19NO11 (545.0958)